Subtype
Benign Musculoskeletal Neoplasm
CI-CAN-00000516Explore in graph →
Non-malignant48 active trials5 evidence items
- NCIt
- C166356
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00000516Explore in graph →
Clinical trials
465 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02361879 | Ulipristal Acetate Versus GnRH Analogue Treatment Before Hysteroscopic Resection of Uterine Leiomyoma | unknown | Phase 4 | 146 | University Magna GraeciaOTHER | 1 | Nov 18, 2016 | clinicaltrials |
| NCT02361905 | Ulipristal Acetate for the Preoperative Management of Hypoechoic Cellular Leiomyomas | unknown | Phase 4 | 42 | University Magna GraeciaOTHER | 1 | Nov 18, 2016 | clinicaltrials |
| NCT01388907 |
| Efficacity Assessment of PREVADH® in Adhesion Prevention in Gynaecologic Surgery |
| completed |
| Phase 4 |
| 61 |
| Medtronic - MITGINDUSTRY |
| 1 |
| Nov 17, 2016 |
| clinicaltrials |
| NCT02288130 | Ulipristal vs. GnRHa Prior to Laparoscopic Myomectomy(MYOMEX) | unknown | Phase 4 | 100 | Amsterdam UMC, location VUmcOTHER | 1 | Nov 3, 2016 | clinicaltrials |
| NCT02884960 | Safety and Efficacy of Embozene Microspheres for Uterine Fibroid Embolization | unknown | N/A | 118 | Gary Siskin, MDOTHER | 0 | Sep 1, 2016 | clinicaltrials |
| NCT01592903 | Somatic Stem Cells in Leiomyomas? | completed | — | 16 | IgenomixINDUSTRY | 1 | Aug 31, 2016 | clinicaltrials |
| NCT01555073 | Preemptive Analgesia Following Uterine Artery Embolization | terminated | Phase 4 | 23 | Northwestern UniversityOTHER | 1 | Jul 28, 2016 | clinicaltrials |
| NCT02819609 | Comparing Patient-Centered Outcomes After Treatment for Uterine Fibroids | completed | — | 12,234 | Quintiles, Inc.INDUSTRY | 0 | Jun 30, 2016 | clinicaltrials |
| NCT00219778 | A Study on the Efficacy of 10 mg Oral Mifepristone for the Treatment of Symptomatic Uterine Leiomyomas | terminated | Phase 2 | 20 | Poitiers University HospitalOTHER | 1 | Apr 6, 2016 | clinicaltrials |
| NCT01675011 | Embozene Microspheres for Uterine Fibroid Embolization (UFE) | terminated | N/A | 4 | Boston Scientific CorporationINDUSTRY | 1 | Mar 11, 2016 | clinicaltrials |
| NCT02440750 | Endometrial Preparation Before Operative Hysteroscopy in Premenopausal Women | unknown | Phase 4 | 50 | University of CagliariOTHER | 0 | Mar 9, 2016 | clinicaltrials |
| NCT01156857 | PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata(PEARLIII) | completed | Phase 3 | 209 | PregLem SAINDUSTRY | 4 | Jan 15, 2016 | clinicaltrials |
| NCT01252069 | PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata (PEARLIII-extension Study) | completed | Phase 3 | 132 | PregLem SAINDUSTRY | 4 | Jan 13, 2016 | clinicaltrials |
| NCT01642472 | PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata(PEARLext2) | completed | Phase 3 | 64 | PregLem SAINDUSTRY | 4 | Jan 8, 2016 | clinicaltrials |
| NCT02620345 | Fibroids in Women of Reproductive Age and Women Pregnancy(Fibroids) | completed | Phase 4 | 22 | Trieu, Nguyen Thi, M.D.INDIV | 0 | Dec 3, 2015 | clinicaltrials |
| NCT01588899 | China Clinical Trial for Therapeutic MR-HIFU Ablation of Uterine Fibroids | completed | N/A | 107 | Philips HealthcareINDUSTRY | 1 | Oct 22, 2015 | clinicaltrials |
| NCT01229826 | Magnetic Resonance Elastography (MRE) of Uterine Fibroids(MRE) | completed | — | 134 | Mayo ClinicOTHER | 1 | Sep 2, 2015 | clinicaltrials |
| NCT00579475 | The Effect of Mifepristone on Uterine Fibroids and Breast Tissue | completed | Phase 1 | 30 | Karolinska InstitutetOTHER | 1 | May 25, 2015 | clinicaltrials |
| NCT02086370 | Prophylactic Salpingectomy for the Prevention of the Ovarian Cancer: Comparison Between Surgical Techniques(Rad_PBS) | completed | N/A | 177 | University Magna GraeciaOTHER | 1 | Apr 21, 2015 | clinicaltrials |
| NCT01671215 | Endometrial and Myometrial Changes, With and Without Fibroids | withdrawn | — | 0 | Meir Medical CenterOTHER | 1 | Apr 15, 2015 | clinicaltrials |
| NCT01226290 | Fibroid Ablation Study(FAST-EU) | terminated | N/A | 51 | GynesonicsINDUSTRY | 3 | Apr 2, 2015 | clinicaltrials |
| NCT01539187 | Fibroid Ablation Study - Large Fibroids(FAST-L) | terminated | N/A | 6 | GynesonicsINDUSTRY | 3 | Mar 17, 2015 | clinicaltrials |
| NCT01998854 | Observational Prospective Study on Patients With Symptomatic Uterine Fibroids Treated With VizAblate® Intrauterine-ultrasound Guided RF Ablation | terminated | — | 4 | GynesonicsINDUSTRY | 1 | Mar 11, 2015 | clinicaltrials |
| NCT01635452 | A Prospective Multicenter Non-interventional Study of Women Treated With ESMYA (Ulipristal Acetate) as Pre-operative Treatment of Moderate to Severe Symptoms of Uterine Fibroids(PREMYA) | unknown | — | 1,500 | PregLem SAINDUSTRY | 10 | Jan 27, 2015 | clinicaltrials |
| NCT01123603 | Lower Urinary Tract Infection (UTI) Evaluation in Women With Uterine Leiomyomata(LOTUS) | completed | — | 860 | The Cleveland ClinicOTHER | 1 | Jan 14, 2015 | clinicaltrials |
| NCT02049242 | Uterine Tourniquet at Open Myomectomy | completed | N/A | 48 | Ataturk UniversityOTHER | 1 | Dec 23, 2014 | clinicaltrials |
| NCT02302651 | Non-invasive Focal Therapy for Osteoid Osteoma | unknown | Phase 2 / Phase 3 | 60 | University of Roma La SapienzaOTHER | 1 | Nov 27, 2014 | clinicaltrials |
| NCT02086279 | AMH Levels Change During Treatment With GnRh Agonist | completed | N/A | 67 | University Magna GraeciaOTHER | 1 | Nov 25, 2014 | clinicaltrials |
| NCT02283502 | Clinical Test of the MRgHIFU System on Uterine Fibroids(MRgHIFU) | unknown | Phase 1 | 20 | Chin-Jung WangOTHER | 1 | Nov 5, 2014 | clinicaltrials |
| NCT00886873 | Mifepristone 10 or 5 mg for 6 Months to Treat Uterine Fibroids(Mifemyo_2) | completed | Phase 2 / Phase 3 | 100 | Mediterranea Medica S. L.OTHER | 1 | Oct 17, 2014 | clinicaltrials |
| NCT01786226 | Mifepristone to Treat Uterine Fibroids | terminated | Phase 2 / Phase 3 | 220 | Mediterranea Medica S. L.OTHER | 1 | Sep 5, 2014 | clinicaltrials |
| NCT01451424 | Evaluation of Safety, Pharmacokinetics, and Efficacy of Proellex Administered Vaginally in Women With Uterine Fibroids | completed | Phase 2 | 40 | Repros Therapeutics Inc.INDUSTRY | 1 | Aug 29, 2014 | clinicaltrials |
| NCT00958893 | An Extension Study Evaluating Safety and Efficacy of Proellex® In Women Who Have Previously Completed ZPU 003 Ext | terminated | Phase 2 | 4 | Repros Therapeutics Inc.INDUSTRY | 1 | Aug 25, 2014 | clinicaltrials |
| NCT00683917 | Pharmacokinetics, Safety and Efficacy Study of Proellex in Pre-menopausal Women With Symptomatic Uterine Fibroids | terminated | Phase 2 | 10 | Repros Therapeutics Inc.INDUSTRY | 2 | Aug 21, 2014 | clinicaltrials |
| NCT00702702 | Safety and Efficacy of Proellex in Pre-menopausal Anemic Women With Symptomatic Uterine Fibroids | terminated | Phase 3 | 56 | Repros Therapeutics Inc.INDUSTRY | 1 | Aug 21, 2014 | clinicaltrials |
| NCT00735553 | Evaluating the Safety and Efficacy of Proellex® (CDB-4124) in Premenopausal Women With Symptomatic Uterine Fibroids | terminated | Phase 3 | 77 | Repros Therapeutics Inc.INDUSTRY | 1 | Aug 21, 2014 | clinicaltrials |
| NCT00737282 | Multicenter Study Evaluating the Safety of Proellex® in Premenopausal Women With Uterine Fibroids | terminated | Phase 3 | 175 | Repros Therapeutics Inc.INDUSTRY | 1 | Aug 21, 2014 | clinicaltrials |
| NCT00785356 | Safety and Efficacy of Proellex in Pre-Menopausal Anemic Women With Symptomatic Uterine Fibroids | terminated | Phase 3 | 8 | Repros Therapeutics Inc.INDUSTRY | 1 | Aug 21, 2014 | clinicaltrials |
| NCT00853567 | Evaluating the Safety and Efficacy of Proellex® in Premenopausal Women With Symptomatic Uterine Fibroids | terminated | Phase 3 | 71 | Repros Therapeutics Inc.INDUSTRY | 1 | Aug 21, 2014 | clinicaltrials |
| NCT01069120 | Safety of 25 and 50 mg Proellex® in the Treatment of Women With Symptomatic Uterine Fibroids | terminated | Phase 3 | 27 | Repros Therapeutics Inc.INDUSTRY | 1 | Aug 21, 2014 | clinicaltrials |
| NCT02061657 | Impact of Misoprostol on Blood Loss In Myomectomy Operations | completed | Phase 3 | 50 | Ain Shams UniversityOTHER | 1 | Aug 12, 2014 | clinicaltrials |
| NCT00882258 | Study of Proellex in Pre-menopausal Women With Symptomatic Uterine Fibroids | completed | Phase 2 | 144 | Repros Therapeutics Inc.INDUSTRY | 1 | Jul 8, 2014 | clinicaltrials |
| NCT00874029 | Laparoscopic Radiofrequency Ablation (RFA) of Symptomatic Uterine Fibroids(Halt) | completed | N/A | 137 | Acessa Health, Inc.INDUSTRY | 3 | Jul 3, 2014 | clinicaltrials |
| NCT00874302 | Safety and Efficacy of 25 and 50 mg Doses of Proellex® in Treating the Recurrence of Uterine Fibroid Symptoms | withdrawn | Phase 3 | 0 | Repros Therapeutics Inc.INDUSTRY | 2 | Jun 27, 2014 | clinicaltrials |
| NCT01829022 | Multi-center Prospective Study on E-NOTES for Myomectomy With Traction of Multidirectional Sutures(E-NOTES) | completed | — | 35 | National Cancer Center, KoreaOTHER_GOV | 1 | Jun 26, 2014 | clinicaltrials |
| NCT02166554 | The Efficacy and Safety Study of a New Cross-linked Hyaluronan Hydrogel in the Reduction of Postsurgical Peritoneal Adhesions(BAP) | completed | Phase 1 / Phase 2 | 216 | BioRegen Biomedical (Changzhou) Co., LtdINDUSTRY | 1 | Jun 18, 2014 | clinicaltrials |
| NCT01816815 | Study in Healthy Tubal Ligated Women to Evaluate Pharmacodynamics, Safety and Pharmacokinetics of BAY1002670 | completed | Phase 1 | 73 | BayerINDUSTRY | 3 | Apr 21, 2014 | clinicaltrials |
| NCT01631903 | Extension of Study ZPV-200 | completed | Phase 2 | 48 | Repros Therapeutics Inc.INDUSTRY | 1 | Apr 16, 2014 | clinicaltrials |
| NCT01739621 | Safety, Pharmacokinetics and Efficacy of Proellex® (Telapristone Acetate) Administered Vaginally in the Treatment of Premenopausal Women With Uterine Fibroids Who Have Completed ZPV-200 | completed | Phase 2 | 40 | Repros Therapeutics Inc.INDUSTRY | 0 | Apr 16, 2014 | clinicaltrials |
| NCT02103933 | Pilot Study to Evaluate the Knowledge and Understanding on Surgery for Patients With Hysterectomy | unknown | — | 200 | National Cancer Center, KoreaOTHER_GOV | 0 | Apr 4, 2014 | clinicaltrials |
Data updated 23 days agoSource updated Nov 18, 2016source: clinicaltrials